𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours

✍ Scribed by C. Csáki; T. Ferencz; D. Schuler; J.D. Borsi

Book ID
117664144
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
108 KB
Volume
34
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant human erythropoietin for the
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
✍ León, Pedro; Jiménez, Miguel; Barona, Pascual; Sierrasesúmaga, Luis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Background. Cancer is often associated with chronic anemia which frequently requires blood transfusions. This study was performed to assess the efficacy and safety of r-HuEPO therapy in children with cancer. Patients and methods. Twenty-five patients under 18 years of age with solid malignant

Recombinant erythropoietin in acute chem
Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer
✍ Beck, Maja Nenadov ;Beck, Daniel 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

## Abstract Chemotherapy‐induced anemia in children with cancer is usually of acute onset. To investigate an alternate treatment to transfusion (Tx), we undertook a phase I‐II clinical trial of daily administrations of recombinant erythropoietin (rHuEPO). Patients with a hemoglobin (Hgb) value <75